256 related articles for article (PubMed ID: 15654705)
1. Rofecoxib for osteoarthritis.
Garner SE; Fidan DD; Frankish R; Maxwell L
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD005115. PubMed ID: 15654705
[TBL] [Abstract][Full Text] [Related]
2. Rofecoxib for rheumatoid arthritis.
Garner SE; Fidan DD; Frankish RR; Judd MG; Towheed TE; Wells G; Tugwell P
Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD003685. PubMed ID: 15674912
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Eccleston C; Cooper TE; Fisher E; Anderson B; Wilkinson NM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012537. PubMed ID: 28770976
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
5. Rofecoxib for the treatment of rheumatoid arthritis.
Garner S; Fidan D; Frankish R; Judd M; Towheed T; Wells G; Tugwell P
Cochrane Database Syst Rev; 2002; (3):CD003685. PubMed ID: 12137705
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia.
Jordan F; Quinn TJ; McGuinness B; Passmore P; Kelly JP; Tudur Smith C; Murphy K; Devane D
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD011459. PubMed ID: 32352165
[TBL] [Abstract][Full Text] [Related]
7. Rofecoxib for the treatment of rheumatoid arthritis.
Garner S; Fidan D; Frankish R; Judd M; Towheed T; Wells G; Tugwell P
Cochrane Database Syst Rev; 2002; (2):CD003685. PubMed ID: 12076502
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Celecoxib for rheumatoid arthritis.
Garner SE; Fidan D; Frankish RR; Judd M; Shea B; Towheed T; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003831. PubMed ID: 28598564
[TBL] [Abstract][Full Text] [Related]
10. Single dose oral rofecoxib for postoperative pain.
Barden J; Edwards J; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2005 Jan; (1):CD004604. PubMed ID: 15674955
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib for rheumatoid arthritis.
Garner S; Fidan D; Frankish R; Judd M; Shea B; Towheed T; Wells G; Tugwell P
Cochrane Database Syst Rev; 2002; (4):CD003831. PubMed ID: 12519610
[TBL] [Abstract][Full Text] [Related]
12. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
Matheson AJ; Figgitt DP
Drugs; 2001; 61(6):833-65. PubMed ID: 11398914
[TBL] [Abstract][Full Text] [Related]
14. Single dose oral rofecoxib for acute postoperative pain in adults.
Bulley S; Derry S; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004604. PubMed ID: 19821329
[TBL] [Abstract][Full Text] [Related]
15. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
16. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.
Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ
JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458
[TBL] [Abstract][Full Text] [Related]
17. The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis.
Watson DJ; Yu Q; Bolognese JA; Reicin AS; Simon TJ
Curr Med Res Opin; 2004 Oct; 20(10):1539-48. PubMed ID: 15462687
[TBL] [Abstract][Full Text] [Related]
18. Acetaminophen for osteoarthritis.
Towheed TE; Maxwell L; Judd MG; Catton M; Hochberg MC; Wells G
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004257. PubMed ID: 16437479
[TBL] [Abstract][Full Text] [Related]
19. A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
Stricker K; Yu S; Krammer G
BMC Musculoskelet Disord; 2008 Sep; 9():118. PubMed ID: 18778469
[TBL] [Abstract][Full Text] [Related]
20. A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
Becker RV; Burke TA; McCoy MA; Trotter JP
Clin Ther; 2003 Feb; 25(2):647-62. PubMed ID: 12749519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
